JosephAnthonyTreatMD

PubMed

• Validation of a Molecular Diagnostic Test for Circulating Tumor DNA by Next-Gen Sequencing.
  Sandra V Fernandez, Yin Fei Tan, Shilpa Rao, Patricia Fittipaldi, Fathima Sheriff, Hossein Borghaei, Efrat Dotan, Jennifer S Winn, Martin J Edelman, Joseph Treat, Juli...> ;International Journal of Molecular Sciences. 2023 Oct 30
• Phase II Randomized Trial of Carboplatin, Pemetrexed, and Bevacizumab With and Without Atezolizumab in Stage IV Nonsquamous Non-Small-Cell Lung Cancer Patients Who Har...
  J Nicholas Bodor, Jyoti D Patel, Heather A Wakelee, Benjamin P Levy, Hossein Borghaei, Bruna Pellini, Michael R Costello, Jonathan E Dowell, Gene Finley, Chao H Huang,...> ;Clinical Lung Cancer. 2023 Nov 1
• 6 citations
  Real-world progression-free survival (rwPFS) and the impact of PD-L1 and smoking in driver-mutated non-small cell lung cancer (NSCLC) treated with immunotherapy.
  J Nicholas Bodor, Jessica R Bauman, Elizabeth A Handorf, Eric A Ross, Margie L Clapper, Joseph Treat> ;Journal of Cancer Research and Clinical Oncology. 2023 May 1
• 287 citations
  PROCLAIM: Randomized Phase III Trial of Pemetrexed-Cisplatin or Etoposide-Cisplatin Plus Thoracic Radiation Therapy Followed by Consolidation Chemotherapy in Locally A...
  Suresh Senan, Anthony Brade, Lu Hua Wang, Johan Vansteenkiste, Shaker R. Dakhil, Bonne Biesma, Maite Martinez Aguillo, Joachim G.J.V. Aerts, Ramaswamy Govindan, Belén ...> ;Journal of Clinical Oncology. 2016 Sep 19
• 19 citations
  Pemetrexed With Platinum Combination as a Backbone for Targeted Therapy in Non-Small-Cell Lung Cancer.
  Thomas E. Stinchcombe, Hossein Borghaei, Scott S. Barker, Joseph Treat, Coleman K. Obasaju> ;Clinical Lung Cancer. 2016 Jan 1
• 16 citations
  Cost-effectiveness of first-line induction and maintenance treatment sequences in non-squamous non-small cell lung cancer (NSCLC) in the U.S.
  Gayathri Kumar, Beth Woods, Lisa M. Hess, Joseph Treat, M.E. Boye, Peter Bryden, Katherine B. Winfree> ;Lung Cancer. 2015 Sep 1
• 17 citations
  Concurrent pemetrexed and radiation therapy in the treatment of patients with inoperable stage III non-small cell lung cancer: a systematic review of completed and ong...
  Hak Choy, David E. Gerber, Jeffrey D. Bradley, Puneeth Iyengar, Matthew J. Monberg, Joseph Treat, Ramaswamy Govindan, Andrew Koustensis, Scott S. Barker, Coleman K. Ob...> ;Lung Cancer. 2015 Mar 1
• 114 citations
  PRONOUNCE: randomized, open-label, phase III study of first-line pemetrexed + carboplatin followed by maintenance pemetrexed versus paclitaxel + carboplatin + bevacizu...
  Ralph Zinner, Coleman K. Obasaju, David R. Spigel, Robert W. Weaver, J. Thaddeus Beck, David M. Waterhouse, Manuel R. Modiano, Borys Hrinczenko, Petros G. Nikolinakos,...> ;Journal of Thoracic Oncology. 2015 Jan 1
• 4 citations
  Pemetrexed use in the adjuvant setting for completely resectable non-small-cell lung cancer.
  George R. Simon, Christian Manegold, Scott S. Barker, Joseph Treat, Carla Visseren-Grul, Coleman K. Obasaju> ;Clinical Lung Cancer. 2013 Nov 1
• 26 citations
  Phase 2 Study of Pemetrexed plus Carboplatin, or Pemetrexed plus Cisplatin with Concurrent Radiation Therapy Followed by Pemetrexed Consolidation in Patients with Favo...
  Hak Choy, Lee S. Schwartzberg, Shaker R. Dakhil, Edward B. Garon, David E. Gerber, Janak K. Choksi, Ramaswamy Govindan, Guangbin Peng, Andrew Koustenis, Joseph Treat, ...> ;Journal of Thoracic Oncology. 2013 Oct 1
• 33 citations
  Comparison of pemetrexed plus cisplatin with other first-line doublets in advanced non-small cell lung cancer (NSCLC): A combined analysis of three phase 3 trials
  Joseph Treat, Giorgio V. Scagliotti, Guangbin Peng, Matthew J. Monberg, Coleman K. Obasaju, Mark A. Socinski> ;Lung Cancer. 2012 May 1
• 15 citations
  A retrospective analysis of outcomes across histological subgroups in a three-arm phase III trial of gemcitabine in combination with carboplatin or paclitaxel versus p...
  Joseph Treat, Martin J. Edelman, Chandra P. Belani, Mark A. Socinski, Matthew J. Monberg, Ruqin Chen, Coleman K. Obasaju> ;Lung Cancer. 2010 Dec 1
• 45 citations
  A randomized, phase III multicenter trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin in patients with advanced or ...
  Joseph Treat, René Gonin, Mark A. Socinski, Martin J. Edelman, Robert B. Catalano, Donna M. Marinucci, Rafat Ansari, H. H. Gillenwater, Kendrith M. Rowland, Robert L. ...> ;Annals of Oncology. 2010 Mar 1
• 19 citations
  Costs of First-Line Doublet Chemotherapy and Lifetime Medical Care in Advanced Non–small-Cell Lung Cancer in the United States
  Kathleen Lang, Martin D. Marciniak, Douglas E. Faries, Michael Stokes, Don P. Buesching, Craig C. Earle, Joseph Treat, S.M. Babineaux, Nathalie Morissette, David M. Th...> ;Value in Health. 2009 Jun 1
• A phase I study of pemetrexed plus carboplatin or cisplatin with concurrent chest radiation therapy (CRT) for patients with locally advanced non-small cell lung cancer...
  Heinzerling JH, Hughes RS, Govindan R, Bradley JD, Schiller J, Peng G, Treat J, Obasaju C, Tran T, Choy H> ;J. Clin. Oncol.. 2009-05-20
• 36 citations
  PROCLAIM: A phase III study of pemetrexed, cisplatin, and radiation therapy followed by consolidation pemetrexed versus etoposide, cisplatin, and radiation therapy fol...
  Everett E. Vokes, Suresh Senan, Joseph Treat, Neill Iscoe> ;Clinical Lung Cancer. 2009 May 1
• 52 citations
  Trends and predictors of first-line chemotherapy use among elderly patients with advanced non-small cell lung cancer in the United States.
  Kathleen Lang, Martin D. Marciniak, Doug Faries, Michael Stokes, Don P. Buesching, Craig C. Earle, Joseph Treat, Nathalie Morissette, David M. Thompson> ;Lung Cancer. 2009 Feb 1
• 5 citations
  Topotecan therapy in patients with relapsed small-cell lung cancer and poor performance status
  Rogerio Lilenbaum, Rudolf M. Huber, Joseph Treat, Gregory A. Masters, Sabine Kaubitzsch, Stephen J. Lane, Paul Wissel> ;Clinical Lung Cancer. 2006 Sep 1
• 19 citations
  Administration of pemetrexed immediately following gemcitabine as front-line therapy in advanced non-small cell lung cancer: A phase II trial
  Joseph Treat, Philip Bonomi, Michael McCleod, Neal P. Christiansen, David M. Mintzer, Matthew J. Monberg, Z. Ye, Ruqin Chen, Coleman K. Obasaju> ;Lung Cancer. 2006 Jul 1
• 5 citations
  Incorporating novel agents with gemcitabine-based treatment of NSCLC
  Joseph Treat> ;Lung Cancer. 2005 Jan 1
• 35 citations
  Topotecan in the treatment of relapsed small cell lung cancer patients with poor performance status
  Joseph Treat, Chao Hui Huang, Stephen R. Lane, Jeremey Levin> ;The Oncologist. 2004 Apr 1
• 7 citations
  Weekly topotecan in the management of lung cancer
  Joseph Treat> ;Lung Cancer. 2003 Aug 1
• 28 citations
  A pilot study of systemic corticosteroid administration in conjunction with intrapleural adenoviral vector administration in patients with malignant pleural mesothelioma.
  Daniel H. Sterman, Katherine L. Molnar-Kimber, Tara D. Iyengar, Michael Chang, Michael Lanuti, Kunjlata M. Amin, Brandon K Pierce, Eugene Kang, Joseph Treat, Adri Reci...> ;Cancer Gene Therapy. 2000 Dec 1
• 256 citations
  Adenovirus-Mediated Herpes Simplex Virus Thymidine Kinase/Ganciclovir Gene Therapy in Patients with Localized Malignancy: Results of a Phase I Clinical Trial in Malign...
  Daniel H. Sterman, Joseph Treat, Leslie A. Litzky, Kunjlata M. Amin, Laura Coonrod, Katherine L. Molnar-Kimber, Adri Recio, Linda Knox, James M. Wilson, Steven M. Albe...> ;Human Gene Therapy. 1998 May 1
• 23 citations
  Treatment of Advanced Mesothelioma with the Recombinant Adenovirus H5.010RSVTK: A Phase 1 Trial (BB-IND 6274)
  Joseph Treat, Larry R. Kaiser, Daniel H. Sterman, Leslie A. Litzky, Alan R. Davis, James M. Wilson, Steven M. Albelda> ;Human Gene Therapy. 1996 Oct 20
• Join now to see all